Lymphocytopenia considering GST genotype and changes in mitochondrial activity under dimethyl fumarate (DMF) treatment in Multiple Sclerosis

被引：0
|
作者：
Werntze, Neele [1 ]
Haupeltshofer, Steffen [2 ,3 ]
Blusch, Alina [1 ]
Lemhoefer, Katharina [1 ]
Skrygan, Marina [4 ]
Susok, Laura [4 ]
Gold, Ralf [1 ]
Gambichler, Thilo [4 ,5 ]
Ellrichmann, Gisa [6 ]
机构：
[1] Catholic Hosp Bochum St Josef Hosp, Dept Neurol, Bochum, Germany
[2] Essen Univ Hosp, Dept Neurol, Essen, Germany
[3] Ctr Translat Neuro & Behav Sci, Essen, Germany
[4] Catholic Hosp Bochum St Josef Hosp, Dept Dermatol, Bochum, Germany
[5] Christian Hosp Unna, Dept Dermatol, Unna, Germany
[6] Klinikum Dortmund gGmbH, Clin Ctr Mitte, Dept Neurol, Dortmund, Germany
来源：
MULTIPLE SCLEROSIS JOURNAL | 2023年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1515/2398
引用
收藏
页码：967 / 967
页数：1
相关论文
共 50 条
  • [31] Legionella infection associated with dimethyl fumarate used for treatment of multiple sclerosis
    Rastas, Charlotte
    Sirignano, David
    Barner, Amanda
    Bruno-Murtha, Lou Ann
    JOURNAL OF NEUROLOGY, 2019, 266 (11) : 2867 - 2868
  • [32] Dimethyl fumarate treatment alters T cell metabolism in multiple sclerosis
    Liebmann, M.
    Janoschka, C.
    Herrmann, A.
    Schulte-Mecklenbeck, A.
    Schwab, N.
    Gross, C. C.
    Koenig, S.
    Meuth, S. G.
    Wiendl, H.
    Klotz, L.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 748 - 749
  • [33] Dimethyl fumarate in the treatment of relapsing-remitting multiple sclerosis: an overview
    Bomprezzi, Roberto
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2015, 8 (01) : 20 - 30
  • [34] Dimethyl fumarate treatment induces changes in lymphocyte subpopulations in multiple sclerosis that could identify "NEDA" patients
    Teniente Serra, Aina
    Presas Rodriguez, Silvia
    Selles Rius, Ares
    Jose Mansilla, M.
    Quirant Sanchez, Bibiana
    Ramo Tello, Cristina
    Martinez Caceres, Eva M.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2021, 51 : 310 - 310
  • [35] Dimethyl fumarate: A fumaric acid ester under investigation for the treatment of relapsing-remitting multiple sclerosis
    Sobieraj, Diana M.
    Coleman, Craig I.
    FORMULARY, 2012, 47 (11) : 386 - 391
  • [36] Lymphopenia In Multiple Sclerosis Patients Under Dimethyl Fumarate - The Experience Of a Portuguese Center
    Silva, A.
    Jorge, A.
    Correia, I.
    Batista, S.
    Nunes, C.
    Macario, C.
    Jorge, A.
    Correia, I.
    Batista, S.
    Sousa, L.
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 636 - 636
  • [37] Longitudinal and Cross Sectional Study of Adipocytokine and Vitamin D in Multiple Sclerosis Patients Treated with Dimethyl Fumarate (DMF)
    Baharnoori, Moogeh
    Gonzalez, Cindy T.
    Saxena, Shrishti
    Keyhanian, Kiandokht
    Kivisakk, Pia
    Healy, Brian C.
    Weiner, Howard
    Chitnis, Tanuja
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (01) : 30 - 30
  • [38] Longitudinal and Cross Sectional Study of Adipocytokine and Vitamin D in Multiple Sclerosis Patients Treated with Dimethyl Fumarate (DMF)
    Baharnoori, Moogeh
    Gonzalez, Cindy T.
    Saxena, Shrishti
    Keyhanian, Kiandokht
    Kivisakk, Pia
    Healy, Brian
    Weiner, Howard
    Chitnis, Tanuja
    NEUROLOGY, 2017, 88
  • [39] Dimethyl fumarate versus interferon for treatment of relapsing-remitting multiple Sclerosis
    Sattarnezhad, Neda
    Healy, Brian C.
    Baharnoori, Moogeh
    Diaz-Cruz, Camilo
    Stankiewicz, James
    Weiner, Howard L.
    Chitnis, Tanuja
    NEUROLOGY, 2017, 88
  • [40] Comparison of Fingolimod and Dimethyl Fumarate in the Treatment of Multiple Sclerosis: Two Year Experience
    Vollmer, Brandi
    Nair, Kavita
    Sillau, Stefan
    Corboy, John
    Vollmer, Timothy
    Alvarez, Enrique
    NEUROLOGY, 2016, 86
12345